SCHEMBL13844206

SCHEMBL13844206

NC(=O)c1cc([N+](=O)[O-])ccc1F

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.60
ALDH1A1 P00352 7/20 0.55
HIF1A Q16665 1/20 0.55
SMN1; SMN2 Q16637 4/20 0.54
TSHR P16473 2/20 0.52
LMNA P02545 2/20 0.51
POLB P06746 2/20 0.50
MITF O75030 1/20 0.50
RAB9A P51151 3/20 0.49
CYP3A4 P08684 3/20 0.49
ALOX15 P16050 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
PKM P14618 1/20 0.48
GAA P10253 1/20 0.47
NPC1 O15118 2/20 0.47
ATM Q13315 1/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4485751 1.00 KMT2A (0.60) KMT2AALDH1A1HIF1ASMN1; SMN2TSHR
SCHEMBL114077 0.86 KMT2A (0.65) KMT2AALDH1A1HIF1ASMN1; SMN2TSHR
SCHEMBL29288675 0.84 KMT2A (0.63) KMT2AALDH1A1HIF1ASMN1; SMN2TSHR
SCHEMBL25090606 0.84 ALDH1A1 (0.53) KMT2AALDH1A1HIF1ASMN1; SMN2TSHR
SCHEMBL1654660 0.84 ALDH1A1 (0.59) KMT2AALDH1A1HIF1ASMN1; SMN2LMNA
SCHEMBL195145 0.84 ALDH1A1 (0.59) KMT2AALDH1A1HIF1ASMN1; SMN2LMNA
SCHEMBL6398309 0.83 KMT2A (0.71) KMT2AALDH1A1SMN1; SMN2TSHRLMNA
Silver SCHEMBL887047 0.82 ALDH1A1 (0.55) KMT2AALDH1A1HIF1ASMN1; SMN2LMNA
SCHEMBL2832 0.82 ALDH1A1 (0.55) KMT2AALDH1A1HIF1ASMN1; SMN2LMNA
SCHEMBL284069 0.82 ALDH1A1 (0.55) KMT2AALDH1A1HIF1ASMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009058919-A1 CCR5 ANTAGONISTS AS THERAPEUTIC AGENTS SMITHKLINE BEECHAM CORPORATION (US) 2009-05-07 WO disclosed